Most of the new regulations stemming from Bill 102, the Transparent Drug System for Patients Act 2006, previously approved by the Ontario government in Canada, will soon come into effect

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.511, 2006-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug discounts planned for elderly, patients' rights bill approved in US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 322, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Cancer and the affordable care act: Despite some challenges, most cancer experts say the new law benefits patients and survivors

By Printz Carrie  

Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. : 1911-1912

Blackwell Publishing

Access to resources Recommend Favorite

New acellular pertussis vaccine superior in Ontario, Canada

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

US government passes bill requiring `reasonable' drug prices

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 269, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharmaceutical Decisions, New Developments and Proposed Regulations: From the Food Drug Cosmetic Law Reporter

By Limited A.I.  

Pharmaceutical Development and Regulation, Vol. 1, Iss. 1, 2003-01 ,pp. : 75-80

Adis International

Access to resources Recommend Favorite